Home Immunotherapy for Cancer Stanford Study Engineers Immune Cells to Target Pediatric Solid Tumors

Stanford Study Engineers Immune Cells to Target Pediatric Solid Tumors

117
0

In ScienceDaily, Stanford Medicine research reports that they were able to design immune cells to attack childhood cancers that were able to eradicate different types of pediatric tumors in mice. Based on the results, the team is now planning a series of phase-1 clinical trials for the B7-H3 CAR-T cells, starting with adult brain tumor patients. B7-H3 is not expressed on healthy tissues in the central nervous system, making it a good starting point for human trials. Follow the link for the entire article.

Lead Research/Investigator

Robbie Majzner, MD

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.